Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 31/10/17 → 28/02/19 |
Funding
- Action Arthritis (Norwich Hip Trust): £15,509.00
Establishing inhibition of MMP-14 as a viable therapeutic in Dupuytren's disease - the ex vivo 'clinical trial'.
- Clark, Ian (Principal Investigator)
- Chojnwoski, Adrian (Co-Investigator)
- Gardner, Sarah (Technician)